What is the maximum recommended dose of tizanidine (Zanaflex)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tizanidine Maximum Dose

The maximum recommended dose of tizanidine is 36 mg per day, though older adults rarely tolerate doses greater than 30-40 mg per day. 1

Standard Dosing Parameters

  • Starting dose: 2 mg up to three times daily, with gradual titration to achieve optimal effect while monitoring for side effects 1
  • Maximum daily dose: 36 mg/day has been used in clinical trials, though wide interpatient variability in effective plasma concentrations means optimal dosage must be titrated over 2 to 4 weeks for each patient 2
  • Typical dosage range: 2 to 36 mg/day, with dosages divided into multiple administrations throughout the day 2

Special Population Considerations

Older Adults

  • Older adults rarely tolerate doses greater than 30-40 mg per day 1
  • The American Geriatrics Society recommends starting at 2 mg up to three times daily with careful monitoring for sedation, somnolence, orthostasis, muscle weakness, urinary function issues, and cognitive effects 1

Renal or Hepatic Impairment

  • Avoid tizanidine in patients with hepatic or renal dysfunction due to significantly reduced clearance and increased risk of adverse effects 3
  • For patients with moderate renal impairment who must use tizanidine, a starting dose of 2 mg twice daily is within appropriate parameters 4

Clinical Achievement of Maximum Dose

  • In clinical trials, only 10 of 47 patients (21%) were able to reach the maximum daily dosage of 36 mg 5
  • Maximum effects occur within 2 hours of administration 2
  • The titration phase typically spans 2 to 4 weeks to reach optimal dosing 2, 6

Critical Safety Warnings at Higher Doses

  • Hypotension risk: Tizanidine can cause significant hypotension, which requires monitoring, particularly at higher doses 3, 1
  • Drug interactions: Tizanidine clearance is significantly reduced when given with CYP1A2 inhibitors, increasing risk of adverse effects and potentially requiring dose reduction 3
  • Discontinuation: Never abruptly discontinue in long-term users; taper slowly to prevent withdrawal symptoms including rebound tachycardia, hypertension, and hypertonia 3, 1

Common Adverse Effects

  • The most frequent side effects are somnolence (62%) and dizziness (32%), with dry mouth also commonly reported 2, 5
  • Adverse events were reported in 91% of tizanidine-treated patients in controlled trials, with 13% discontinuing treatment due to side effects 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.